Kano Therapeutics Inc

Kano Therapeutics develops circular single-stranded DNA (cssDNA) as a payload platform for genetic medicine applications, including CRISPR gene editing, targeted insertion therapies, and episomal expression. The company manufactures cssDNA using fermentation-based methods and partners with therapeutic developers to license and supply the DNA products for cell and gene therapy development from discovery through clinical manufacture.